Yoan Cherasse Selected Research

Adenosine (Adenocard)

1/2019

Enhancing endogenous adenosine A2A receptor signaling induces slow-wave sleep without affecting body temperature and cardiovascular function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoan Cherasse Research Topics

Disease

4	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2023 - 10/2015
3	Starvation 12/2009 - 11/2008
2	Narcolepsy 01/2024 - 01/2021
2	Mania (Manias) 01/2023 - 06/2020
2	Seizures (Absence Seizure) 11/2018 - 01/2017
1	Idiopathic Hypersomnia 01/2024
1	Central Nervous System Diseases (CNS Diseases) 01/2024
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2024
1	Schizophrenia (Dementia Praecox) 01/2023
1	Cataplexy 01/2021
1	Sleep Wake Disorders 01/2019
1	Pain (Aches) 12/2017
1	Infections 07/2011
1	Malnutrition (Nutritional Deficiencies) 07/2010

Drug/Important Bio-Agent (IBA)

3	Amino Acids FDA Link 12/2009 - 11/2008
2	Orexin Receptor AntagonistsIBA 01/2023 - 01/2021
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2023 - 01/2019
2	Small Interfering RNA (siRNA)IBA 07/2011 - 12/2009
1	Genetic Markers (Genetic Marker)IBA 01/2024
1	NucleotidesIBA 01/2024
1	DNA (Deoxyribonucleic Acid)IBA 01/2024
1	Diazepam (Valium)FDA LinkGeneric 01/2023
1	Hypnotics and Sedatives (Sedatives)IBA 01/2023
1	BenzodiazepinesIBA 01/2023
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2023
1	DORA-22IBA 01/2023
1	suvorexantIBA 01/2021
1	OrexinsIBA 01/2021
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 06/2020
1	Dopamine (Intropin)FDA LinkGeneric 06/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2019
1	ProstaglandinsIBA 11/2018
1	Prostaglandin D2IBA 11/2018
1	Pentylenetetrazole (Metrazol)IBA 11/2018
1	EnzymesIBA 11/2018
1	ParvalbuminsIBA 12/2017
1	Designer DrugsIBA 12/2017
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2017
1	AM 251 (AM251)IBA 01/2017
1	1-pentyl-3-(1-naphthoyl)indoleIBA 01/2017
1	CannabinoidsIBA 01/2017
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2017
1	Divalent CationsIBA 10/2015
1	ManganeseIBA 10/2015
1	IronIBA 10/2015
1	CopperIBA 10/2015
1	Caffeine (No Doz)FDA LinkGeneric 07/2011
1	Proteins (Proteins, Gene)FDA Link 07/2010
1	Sirolimus (Rapamycin)FDA Link 02/2009
1	Leucine (L-Leucine)FDA Link 02/2009

Therapy/Procedure

1	Therapeutics 01/2017